Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH Study
Titel:
Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH Study
Auteur:
Cortes, Jorge E. Lipton, Jeffrey H. Miller, Carole B. Busque, Lambert Akard, Luke P. Pinilla-Ibarz, Javier Keir, Christopher Warsi, Ghulam Lin, Felice P. Mauro, Michael J.